Table of Contents

1 Study Coverage

• 1.1 Anastrozole Tablets Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Anastrozole Tablets Market Size Growth Rate by Product
  • 1.4.2 Arimidex
  • 1.4.3 Generic
• 1.5 Market by End User
  • 1.5.1 Global Anastrozole Tablets Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Drug store
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Anastrozole Tablets Market Size
  • 2.1.1 Global Anastrozole Tablets Revenue 2014-2025
  • 2.1.2 Global Anastrozole Tablets Sales 2014-2025
• 2.2 Anastrozole Tablets Growth Rate by Regions
  • 2.2.1 Global Anastrozole Tablets Sales by Regions
  • 2.2.2 Global Anastrozole Tablets Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Anastrozole Tablets Sales by Manufacturers
  • 3.1.1 Anastrozole Tablets Sales by Manufacturers
  • 3.1.2 Anastrozole Tablets Sales Market Share by Manufacturers
  • 3.1.3 Global Anastrozole Tablets Market Concentration Ratio (CR5 and HHI)
• 3.2 Anastrozole Tablets Revenue by Manufacturers
  • 3.2.1 Anastrozole Tablets Revenue by Manufacturers (2014-2019)
  • 3.2.2 Anastrozole Tablets Revenue Share by Manufacturers (2014-2019)
• 3.3 Anastrozole Tablets Price by Manufacturers
• 3.4 Anastrozole Tablets Manufacturing Base Distribution, Product Types
  • 3.4.1 Anastrozole Tablets Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Anastrozole Tablets Product Type
  • 3.4.3 Date of International Manufacturers Enter into Anastrozole Tablets Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Anastrozole Tablets Sales by Product
• 4.2 Global Anastrozole Tablets Revenue by Product
• 4.3 Anastrozole Tablets Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Anastrozole Tablets Breakdown Data by End User

6 North America

• 6.1 North America Anastrozole Tablets by Countries
  • 6.1.1 North America Anastrozole Tablets Sales by Countries
  • 6.1.2 North America Anastrozole Tablets Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Anastrozole Tablets by Product
• 6.3 North America Anastrozole Tablets by End User

7 Europe

• 7.1 Europe Anastrozole Tablets by Countries
  • 7.1.1 Europe Anastrozole Tablets Sales by Countries
  • 7.1.2 Europe Anastrozole Tablets Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Anastrozole Tablets by Product
• 7.3 Europe Anastrozole Tablets by End User

8 Asia Pacific

• 8.1 Asia Pacific Anastrozole Tablets by Countries
  • 8.1.1 Asia Pacific Anastrozole Tablets Sales by Countries
  • 8.1.2 Asia Pacific Anastrozole Tablets Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Anastrozole Tablets by Product
• 8.3 Asia Pacific Anastrozole Tablets by End User

9 Central & South America

• 9.1 Central & South America Anastrozole Tablets by Countries
  • 9.1.1 Central & South America Anastrozole Tablets Sales by Countries
  • 9.1.2 Central & South America Anastrozole Tablets Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Anastrozole Tablets by Product
• 9.3 Central & South America Anastrozole Tablets by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Anastrozole Tablets by Countries
  • 10.1.1 Middle East and Africa Anastrozole Tablets Sales by Countries
  • 10.1.2 Middle East and Africa Anastrozole Tablets Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Anastrozole Tablets by Product
• 10.3 Middle East and Africa Anastrozole Tablets by End User

11 Company Profiles

• 11.1 AstraZeneca
  • 11.1.1 AstraZeneca Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 AstraZeneca Anastrozole Tablets Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 AstraZeneca Anastrozole Tablets Products Offered
  • 11.1.5 AstraZeneca Recent Development
• 11.2 Zydus Pharmaceuticals
  • 11.2.1 Zydus Pharmaceuticals Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Zydus Pharmaceuticals Anastrozole Tablets Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Zydus Pharmaceuticals Anastrozole Tablets Products Offered
  • 11.2.5 Zydus Pharmaceuticals Recent Development
• 11.3 Teva
  • 11.3.1 Teva Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Teva Anastrozole Tablets Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Teva Anastrozole Tablets Products Offered
  • 11.3.5 Teva Recent Development
• 11.4 Hikma Pharmaceuticals
  • 11.4.1 Hikma Pharmaceuticals Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Hikma Pharmaceuticals Anastrozole Tablets Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Hikma Pharmaceuticals Anastrozole Tablets Products Offered
  • 11.4.5 Hikma Pharmaceuticals Recent Development
• 11.5 Natco Pharma
  • 11.5.1 Natco Pharma Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Natco Pharma Anastrozole Tablets Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Natco Pharma Anastrozole Tablets Products Offered
  • 11.5.5 Natco Pharma Recent Development
• 11.6 Fresenius Kabi
  • 11.6.1 Fresenius Kabi Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Fresenius Kabi Anastrozole Tablets Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Fresenius Kabi Anastrozole Tablets Products Offered
  • 11.6.5 Fresenius Kabi Recent Development
• 11.7 Accord Healthcare
  • 11.7.1 Accord Healthcare Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Accord Healthcare Anastrozole Tablets Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Accord Healthcare Anastrozole Tablets Products Offered
  • 11.7.5 Accord Healthcare Recent Development
• 11.8 Mylan
  • 11.8.1 Mylan Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Mylan Anastrozole Tablets Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Mylan Anastrozole Tablets Products Offered
  • 11.8.5 Mylan Recent Development
• 11.9 Cipla
  • 11.9.1 Cipla Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Cipla Anastrozole Tablets Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Cipla Anastrozole Tablets Products Offered
  • 11.9.5 Cipla Recent Development
• 11.10 Apotex
  • 11.10.1 Apotex Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Apotex Anastrozole Tablets Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Apotex Anastrozole Tablets Products Offered
  • 11.10.5 Apotex Recent Development
• 11.11 HISUN
• 11.12 Chongqing Huapont Pharmaceutical
• 11.13 Zhejiang Wansheng Pharmaceutical
• 11.14 Yangtze River Pharmaceutical Group

12 Future Forecast

• 12.1 Anastrozole Tablets Market Forecast by Regions
  • 12.1.1 Global Anastrozole Tablets Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Anastrozole Tablets Revenue Forecast by Regions 2019-2025
• 12.2 Anastrozole Tablets Market Forecast by Product
  • 12.2.1 Global Anastrozole Tablets Sales Forecast by Product 2019-2025
  • 12.2.2 Global Anastrozole Tablets Revenue Forecast by Product 2019-2025
• 12.3 Anastrozole Tablets Market Forecast by End User
• 12.4 North America Anastrozole Tablets Forecast
• 12.5 Europe Anastrozole Tablets Forecast
• 12.6 Asia Pacific Anastrozole Tablets Forecast
• 12.7 Central & South America Anastrozole Tablets Forecast
• 12.8 Middle East and Africa Anastrozole Tablets Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Anastrozole Tablets Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Anastrozole is a drug used to treat breast cancer in post-menopausal women.
The global Anastrozole Tablets market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anastrozole Tablets market based on company, product type, end user and key regions.

This report studies the global market size of Anastrozole Tablets in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anastrozole Tablets in these regions.
This research report categorizes the global Anastrozole Tablets market by top players/brands, region, type and end user. This report also studies the global Anastrozole Tablets market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca
Zydus Pharmaceuticals
Teva
Hikma Pharmaceuticals
Natco Pharma
Fresenius Kabi
Accord Healthcare
Mylan
Cipla
Apotex
HISUN
Chongqing Huapont Pharmaceutical
Zhejiang Wansheng Pharmaceutical
Yangtze River Pharmaceutical Group

Market size by Product
Arimidex
Generic
Market size by End User
Hospital
Drug store

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Anastrozole Tablets market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Anastrozole Tablets market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anastrozole Tablets companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Anastrozole Tablets submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anastrozole Tablets are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anastrozole Tablets market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.